SREBP2, the nuclear transcription factor that serves as the master regulator of cholesterol metabolism, is deemed as an important candidate for genetic susceptibility of non-obese NAFLD. This evidence concerns the gene SREBF2 and metabolic dysfunction-associated steatotic liver disease.